Stock fact sheet · data as of

The Merger Fund - Class A (MERFX): fair value, margin of safety and Wheel Score

Financial Services · Asset Management · United States · High Yield Income

Close17.77
GLS fair value18.831 of 9 models
Margin of safety+6%price below fair value
Wheel Score39No optionscapped: no options
Health4/9Piotroski F-score
Moat3.9/10GLS 10-year score
Market cap$2.6B
Implied vol.-no listed options
P/E-EPS 0.00
Dividend yield7.20%payout 0%
Beta0.01moves less than the market
Next earnings-no date recorded

Is MERFX undervalued?

MERFX closed at 17.77 on 16 Oct 2026 against a GLS average fair value of 18.83 - 5.6% below fair value, which our screens read as "fairly priced". 1 of 1 models are above the current price. There is no discount to lean on here, so the margin of safety is not the reason to look at the stock.

Only 1 of the nine models produced a value (DDM); the others need a dividend, positive free cash flow or positive book value the company does not have yet, so the average rests on a narrow base.

The nightly engine files MERFX under High Yield Income: a dividend yield above 4%.

Nine valuation models for MERFX

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF--Present value of the projected free cash flows, discounted at the cost of capital; no value tonight
Graham Number--The most a defensive investor pays for the earnings and book value per share; no value tonight
Graham Growth--Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight
Lynch--EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight
GLS Growth--EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight
10 Cap--Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%; no value tonight
Payback Time--Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight
DDM18.83+6%Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend
EPV--Earnings power value: current EPS capitalised at 9% with no growth; no value tonight
Zombie (liquidation)0.0001-100%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target0.0000-100%Analysts' average 12-month price target. Not in the average

Quality and financial health

Financial health is weak: MERFX passes 4 of the nine Piotroski tests. Our screens drop the stock at the health rule; a low score is often the reason a stock looks cheap on the valuation models. The GLS Moat score is low at 3.9 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.

Returns on capital are moderate - ROIC 5.3%, ROE 5.3%, ROA 5.3% - with debt at 0.00 times equity and negative free cash flow.

The dividend yield is high at 7.20% (payout ratio 0%). A yield this size is often the market's way of pricing a risk to the payout, so the health score and cash flow matter more than usual.

Institutional ownership scores 5/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score4 / 9ROIC5.3%
GLS Moat3.9 / 10ROE5.3%
Debt / equity0.00ROA5.3%
Free-cash-flow yield0.0%Payout ratio0%
Institutions5 / 10Insiders · Congress5 · 5 / 10

Wheel Score 39: No options

MERFX has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business; the Wheel Score is capped at 39 and shown as "No options" (39 here). The valuation and quality numbers still apply to owning the shares outright.

Volume runs at - a day on a market cap of $2.6B, with a beta of 0.01 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 10 of 20.

PartPointsFrom
Value15 / 256% margin of safety
Health9 / 20Piotroski 4/9
Moat6 / 15moat 3.9/10
Premium0 / 20no option data
Stability10 / 200k shares/day, $2.6B cap, beta 0.01

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for MERFX in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Asset Management

The 12 companies below are the closest to The Merger Fund - Class A by market cap within the Asset Management industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
ASST
Strive, Inc.
25.65--45Weak$2.6B
BDOAX
iShares MSCI Total International Index Fund - Class A
13.8427.71+50%39No options$2.5B
JTSSX
JPMorgan SmartRetirement 2050 Fund Class I
27.667,879.39+100%39No options$2.7B
AIVFX
American Funds International Vantage Fund
21.3410.03-113%20No options$2.7B
GDV
The Gabelli Dividend & Income Trust
28.52122.93+77%39No options$2.5B
UTF
Cohen & Steers Infrastructure Fund, Inc
25.5281.13+69%39No options$2.5B
ABXL
Abacus Global Management, Inc. - 9.875% Fixed Rate Senior Notes due 2028
25.1919.72-28%18No options$2.5B
KLMN
Invesco Exchange-Traded Fund Trust II - Invesco MSCI North America Climate ETF
31.552.83-1015%21No options$2.5B
CHCLX
AB Discovery Growth Fund, Inc. - Class A
11.539.61-20%27No options$2.5B
OXLCM
Oxford Lane Capital Corp.
24.9869.99+64%39No options$2.4B
FBTAX
Fidelity Advisor Biotechnology Fund Class A
45.4327.33-66%39No options$2.4B
LCGNX
William Blair Large Cap Growth N
28.4837.96+25%39No options$2.8B

⚖ Compare MERFX with 7 of them   All Financial Services stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about MERFX

Is MERFX undervalued right now?

Not meaningfully: at 17.77 the stock trades within a few percent of the GLS average fair value of 18.83 (5.6% below fair value, data as of 16 Oct 2026).

What is the Wheel Score of MERFX and what does it mean?

MERFX has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for MERFX?

18.83 per share as of 16 Oct 2026 - the simple average of the 1 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does The Merger Fund - Class A report earnings next?

No upcoming earnings date is recorded for MERFX in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.

Does MERFX have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on MERFX, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.